BACE1 and Alzheimer disease: Given that elevated neuronal BACE1 activity is closely relevant with Aβ generation in the brains of AD patients, inhibition of BACE1 is recognized as a promising alternative strategy, which can reduce the deposition of Aβ directly [11].